DeBogy Molecular Announces New Capital Raise to Bring Innovative Antimicrobial Technology to Market
November 19, 2024 07:00 AM Eastern Standard Time FARMINGTON, Conn.–(BUSINESS WIRE)–DeBogy Molecular, Inc, a privately held biotech that specializes in antimicrobial surface modification, announced their Board of Directors has approved a new capital raise to support…